Concepedia

Author

Lidija Savić

Centar za Promociju NaukeORCID

Also Known As

L Savic, L Savić, L. Savic, LIDIJA SAVIC, Lidija Savic, Lidija Savic-Spasic, Lidija Savić, Lidija Z Savic, Lidija Zlatimir Savic

78

Publications

798

Citations

13

H-Index

21

Concepts

All Affiliations

Centar za Promociju NaukeUniversity of BelgradeInstitute for Cardiovascular Diseases of Vojvodina
LS

About

Lidija Savić is an author at Centar za Promociju Nauke specializing in cardiovascular disease, cardiology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

135

2

Public Health

4

4

119

3

Epidemiology

3

3

89

4

Emergency Medicine

2

2

49

5

Health Policy

1

1

36

Lidija Savić

×

14

Publications

623

Citations

12

H-Index

YearCitations

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Derek J. Hausenloy, Rajesh Kharbanda, Ulla Møller,

The Lancet

2019

309

Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention

Igor Mrdović, Lidija Savić, Gordana Krljanać,

Coronary Artery Disease

2011

48

Sex-Related Analysis of Short- and Long-term Clinical Outcomes and Bleeding Among Patients Treated With Primary Percutaneous Coronary Intervention: An Evaluation of the RISK-PCI Data

Igor Mrdović, Lidija Savić, Milika Ašanin,

Canadian Journal of Cardiology

2013

40

Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score

Igor Mrdović, Lidija Savić, Gordana Krljanać,

International Journal of Cardiology

2011

36

B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

Milika Ašanin, Sanja Stanković, Igor Mrdović,

Peptides

2012

30

Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention

Dragan Matić, Dejan Milašinović, Milika Ašanin,

Heart

2013

29

Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register

Igor Mrdović, Lidija Savić, Ratko Lasica,

European Heart Journal Acute Cardiovascular Care

2013

29

Simple Risk Algorithm to Predict Serious Bleeding in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Igor Mrdović, Lidija Savić, Gordana Krljanać,

Circulation Journal

2013

23

Development and Validation of a Risk Scoring Model to Predict Net Adverse Cardiovascular Outcomes after Primary Percutaneous Coronary Intervention in Patients Pretreated with 600 mg Clopidogrel: Rationale and Design of the RISK‐PCI Study

Igor Mrdović, Lidija Savić, Jovan Peruničić,

Journal of Interventional Cardiology

2009

16

Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction

Igor Mrdović, Lidija Savić, Jovan Peruničić,

American Heart Journal

2007

16

Page 1